- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Medicare Advantage Enrollment Rose, Despite ACA, Kaiser Report Shows
A recent report from the Kaiser Family Foundation found that inital concern over Medicare Advantage enrollment decreasing due to healthcare reform is unfounded. Rates of enrollment have actually increased:
Despite concern that the healthcare reform law would dampen Medicare Advantage enrollment, the opposite has happened so far, according the Kaiser Family Foundation.
Between the beginning of 2012 and March 2013, 1 million more beneficiaries enrolled in the program, a nearly 10% year-over-year increase, bringing total Medicare Advantage enrollment to 14.4 million this year, according to a new report by Kaiser and Mathematica Policy Research. Since 2009, enrollment in MA had grown 30%.
Under the Patient Protection and Affordable Care Act, Medicare payments to Advantage plans last year began to depend on the correlation between their bids and fee-for-service costs in individual counties, though payments to plans can also increase based on quality of service provided. While 2011 payments were held at 2010 levels, the maximum amount a plan could be paid by Medicare began to go down in 2012.
The Kaiser and Mathematic researchers found that the changes didn't negatively affect enrollment in Advantage plans. “There is little evidence of an adverse effect on enrollment in low- versus high-cost counties,” the study says.
Read the full story here: http://bit.ly/19ZwwHo
Source: Modern Healthcare
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
